Supplementary Data from Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

Authors:
  • ZWZhijie Wang
    Zhijie Wang
  • JZJing Zhao
    Jing Zhao
  • GWGuoqiang Wang
    Guoqiang Wang
  • FZFan Zhang
    Fan Zhang
  • ZZZemin Zhang
    Zemin Zhang
  • YZYuzi Zhang
    Yuzi Zhang
  • HDHua Dong
    Hua Dong
  • XZXiaochen Zhao
    Xiaochen Zhao
  • JDJianchun Duan
    Jianchun Duan
  • HBHua Bai
    Hua Bai
  • YTYanhua Tian
    Yanhua Tian
  • RWRui Wan
    Rui Wan

Abstract
The supplemental material provides a detailed list of data, DNA repair response genes and immune gene signature used in the present study. Co-mutation in HRR and BER or HRR and MMR was associated with tumor mutational burden and neoantigen load in most tumors. Single-mutated DDR pathway could not differentiate patients who could response to immunotherapy in the four clinical cohorts. Co-mutation status was compared with PD-1 expression or TMB in the clinical cohorts. In the melanoma cohorts, co-mutation status also predicted improved OS and ORR in the TMB stratification analysis, though significant P values were not reached.